Clinical trials

  • TARLATAMAB for Small cell lung cancer (extensive stage)
  • 18F-Fluorocholine for Multiple myeloma
  • ATEZOLIZUMAB for Non-small cell lung cancer
  • ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE 2 ENCODING GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR for Parkinson's disease
  • Amivantamab for Non-small cell lung cancer (NSCLC) with oncogenic EGFR mutation
  • ALLOGENEIC ADIPOSE-DERIVED MESENCHYMAL STROMAL CELLS, EX-VIVO EXPANDED for Systemic sclerosis
  • FASUDIL HYDROCHLORIDE for Alzheimer's disease
  • CISPLATIN for Anal squamous cell carcinoma (locally advanced)
  • CROVALIMAB for Paroxysmal nocturnal hemoglobinuria
  • TINENGOTINIB for Cholangiocarcinoma
  • Clinical trial in Cervical cancer|Cervical cancer stage I
  • Adeno-associated virus serotype 9 vector containing the human LAMP2 isoform B transgene for Danon disease